Advertisement
Screener

ASSERTIO THERAPEUTICS, INC. Forms 3, 4 and 5: Restricted Stock Units and Performance Rights, 2013

ASSERTIO THERAPEUTICS, INC. Forms 3, 4 and 5: Restricted Stock Units and Performance Rights

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 5 rows in 2013. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2013-02-07: Reporting owner Sweeney Michael MD; Form 4; Security Restricted Stock Unit; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2013-02-07: Reporting owner Schoeneck James A; Form 4; Security Restricted Stock Unit; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2013-02-07: Reporting owner Moretti August J; Form 4; Security Restricted Stock Unit; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2013-02-07: Reporting owner Gosling Matthew M; Form 4; Security Restricted Stock Unit; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2013-02-07Sweeney Michael MD
Officer (CMO and VP, R&D)
4Restricted Stock Unit
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+28,500
28,500 owned after
$0.002013-02-11
2013-02-07Schoeneck James A
Director, Officer (President and CEO)
4Restricted Stock Unit
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+105,000
105,000 owned after
$0.002013-02-11
2013-02-07Moretti August J
Officer (Chief Financial Officer)
4Restricted Stock Unit
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+28,500
28,500 owned after
$0.002013-02-11
2013-02-07Gosling Matthew M
Officer (Senior VP, General Counsel)
4Restricted Stock Unit
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+30,500
30,500 owned after
$0.002013-02-11
2013-02-07Vargas Thadd M
Officer (Senior VP, BD)
4Restricted Stock Unit
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+28,500
28,500 owned after
$0.002013-02-11